Loading...
XTAECNTC
Market cap1mUSD
Dec 19, Last price  
150.80ILS
1D
2.94%
1Q
-35.97%
IPO
-98.04%
Name

Cannabotech Ltd

Chart & Performance

D1W1MN
XTAE:CNTC chart
P/E
P/S
EPS
Div Yield, %
0.00%
Shrs. gr., 5y
Rev. gr., 5y
%
Revenues
1m
00153,00001,219,000
Net income
-16m
-6,508,000-13,258,000-29,532,0000-16,122,000
CFO
-8m
-1,581,000-6,800,000-16,015,0000-8,292,000
Earnings
Feb 10, 2025

Profile

CannaboTech Ltd engages in developing cannabinoid-based medication and healthcare products. It provides drugs for various indications; personalized cannabinoid-based products; and CBD-based skincare and food-supplement products. The company is based in Rishon LeZion, Israel.
IPO date
Jul 25, 2021
Employees
Domiciled in
IL
Incorporated in
IL

Valuation

Title
in thousands, except ratios and share amounts
FYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT